4//SEC Filing
Hebert Peter 4
Accession 0000905718-21-001582
CIK 0001601830other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 8:57 PM ET
Size
13.9 KB
Accession
0000905718-21-001582
Insider Transaction Report
Form 4
Hebert Peter
Other
Transactions
- Other
Class A common stock
2021-12-07−4,265,576→ 13,021,519 total
Lux Venture Partners IV, LLC
10% Owner
Transactions
- Other
Class A common stock
2021-12-07−4,265,576→ 13,021,519 total
Lux Ventures IV, L.P.
10% Owner
Transactions
- Other
Class A common stock
2021-12-07−4,265,576→ 13,021,519 total
Lux Co-Invest Opportunities, L.P.
10% Owner
Transactions
- Other
Class A common stock
2021-12-07−4,265,576→ 13,021,519 total
Wolfe Josh
Other
Transactions
- Other
Class A common stock
2021-12-07−4,265,576→ 13,021,519 total
Lux Co-Invest Partners, LLC
10% Owner
Transactions
- Other
Class A common stock
2021-12-07−4,265,576→ 13,021,519 total
Footnotes (1)
- [F1]Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001683771
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 8:57 PM ET
- Size
- 13.9 KB